menu
    • menu

    Alfred E Tiefenbacher GmbH's In & Out Licensing Opportunities, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations shared on PharmaCompass.com

    Default Key Product, Service and Excipients
    News
    Tiefenbacher API+ Ingredients Offers Custom Synthesis Of Intermediates & Apis

    08 May 2024

    // PRESS RELEASE

    Tiefenbacher Group Renovation Of Headquarters In Hamburg

    02 May 2024

    // PRESS RELEASE

    Tiefenbacher Pharmaceuticals successfully prepares the launch of the anticoagulant Rivaroxaban.

    09 Apr 2024

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    Tiefenbacher Group

    Contact Supplier

    Website

    CPhI Worldwide, Milan

    Booth #24A21

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    We are the TIEFENBACHER GROUP, Health Pioneers since 1963.

    Related CompaniesRelated Companies

    About

    As a key component of the TIEFENBACHER GROUP, a 100% family-owned leader in healthcare, we offer comprehensive solutions across the entire life cycle of pharmaceutical products. Our expertise spans the development, manufacturing, and registration of generic, value-added, and innovative medicines, along with e-health solutions tailored for our B2B clients & distribution partners. Trusted globally, our outstanding capabilities in crafting top-tier dossiers and managing intricate product launches in over 80 countries. Our in-house laboratories and manufacturing facilities in India and Cyprus enable us to establish efficient supply chains.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Alfred E Tiefenbacher GmbHGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Van-der-Smissen-Strasse 1, 22767 Hamburg
    Telephone
    Telephone
    +49 404418090
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://aet.eu/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/alfred-e.-tiefenbacher-gmbh-&-co.-kg-/
    youtube
    YouTube
    Twitter
    Twitter
    Contact Info
    Others

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    cphi-worldwide-milan-70313.png

    CPhI Worldwide, Milan

    Booth #24A21

    envelop Contact Supplier

    CPhI Worldwide, Milan

    Contact Supplier

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/tiefenbacher-api-ingredients-gmbh-party-content-89424.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/tiefenbacher-group-party-content-21386.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    API Product List 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/tiefenbacher-api-ingredients-gmbh-party-content-96648.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    R&D API Product List 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/tiefenbacher-api-ingredients-gmbh-party-content-97507.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Veterinary API Product List 2023

    read-more

      https://www.pharmacompass.com/pdf/party/content/tiefenbacher-api-ingredients-gmbh-party-content-987.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    GMP Certificate 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/tiefenbacher-group-party-content-26459.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Tiefenbacher Group & OnDosis Enter Strategic Partnership

    read-more

      https://www.pharmacompass.com/pdf/party/content/tiefenbacher-group-party-content-7484.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    Tiefenbacher API+ Ingredients Offers Custom Synthesis Of Intermediates & Apis
    Tiefenbacher API+ Ingredients Offers Custom Synthesis Of Intermediates & Apis

    08 May 2024

    // PRESS RELEASE

    https://tiefenbacher-pharmaceuticals.com/2024/05/08/tiefenbacher-api-ingredients-offers-custom-synthesis-of-intermediates-apis/

    PRESS RELEASE
    08 May 2024
    Share Share
    Tiefenbacher Group Renovation Of Headquarters In Hamburg
    Tiefenbacher Group Renovation Of Headquarters In Hamburg

    02 May 2024

    // PRESS RELEASE

    https://tiefenbacher-pharmaceuticals.com/2024/05/02/tiefenbacher-group-renovation-of-headquarters-in-hamburg/

    PRESS RELEASE
    02 May 2024
    Share Share
    Tiefenbacher Pharmaceuticals successfully prepares the launch of the anticoagulant Rivaroxaban.
    Tiefenbacher Pharmaceuticals successfully prepares the launch of the anticoagulant Rivaroxaban.

    09 Apr 2024

    // PRESS RELEASE

    https://tiefenbacher-pharmaceuticals.com/2024/04/09/tiefenbacher-first-to-market-launch-rivaroxaban/

    PRESS RELEASE
    09 Apr 2024
    Share Share
    Tiefenbacher Group welcome our new COO for AET Laboratories, Sandip Tarate
    Tiefenbacher Group welcome our new COO for AET Laboratories, Sandip Tarate

    08 Apr 2024

    // PRESS RELEASE

    https://tiefenbacher-pharmaceuticals.com/2024/04/08/tiefenbacher-group-welcomes-new-coo-sandip-tarate/

    PRESS RELEASE
    08 Apr 2024
    Share Share
    Tiefenbacher Group awarded the EcoVadis Silver Medal!
    Tiefenbacher Group awarded the EcoVadis Silver Medal!

    19 Mar 2024

    // PRESS RELEASE

    https://tiefenbacher-pharmaceuticals.com/2024/03/19/tiefenbacher-group-awarded-ecovadis-silver-medal/

    PRESS RELEASE
    19 Mar 2024
    Share Share
    Tiefenbacher Group on awareness for rare disease day
    Tiefenbacher Group on awareness for rare disease day

    29 Feb 2024

    // PRESS RELEASE

    https://tiefenbacher-pharmaceuticals.com/2024/02/29/tiefenbacher-group-on-awareness-for-rare-disease-day/

    PRESS RELEASE
    29 Feb 2024
    Share Share

    FDA Orange Book

    read-more
    read-more

    01

    Brand Name : LEFLUNOMIDE

    Germany
    CPhI Worldwide, Milan
    Booth #24A21
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWe are the TIEFENBACHER GROUP, Health Pioneers since 1963.

    RLD : No

    TE Code : AB

    LEFLUNOMIDE

    Alfred E Tiefenbacher GmbH

    Dosage Form : TABLET; ORAL

    Proprietary Name : LEFLUNOMIDE

    Dosage Strength : 10MG

    Approval Date : 2021-05-10

    Application Number : 213497

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    Tiefenbacher Compnay Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Brand Name : LEFLUNOMIDE

    Germany
    CPhI Worldwide, Milan
    Booth #24A21
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWe are the TIEFENBACHER GROUP, Health Pioneers since 1963.

    RLD : No

    TE Code : AB

    LEFLUNOMIDE

    Alfred E Tiefenbacher GmbH

    Dosage Form : TABLET; ORAL

    Proprietary Name : LEFLUNOMIDE

    Dosage Strength : 20MG

    Approval Date : 2021-05-10

    Application Number : 213497

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    Tiefenbacher Compnay Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Brand Name : POSACONAZOLE

    Germany
    CPhI Worldwide, Milan
    Booth #24A21
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothWe are the TIEFENBACHER GROUP, Health Pioneers since 1963.

    RLD : No

    TE Code : AB

    POSACONAZOLE

    Alfred E Tiefenbacher GmbH

    Dosage Form : TABLET, DELAYED RELEASE; ORAL

    Proprietary Name : POSACONAZOLE

    Dosage Strength : 100MG

    Approval Date : 2021-02-01

    Application Number : 213454

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    Tiefenbacher Compnay Banner

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Inspections and registrations

    Check the inspections & registration from this company

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search